The type of severe allergic reaction which may cause due to food, insect bites, latex or medications is known as anaphylaxis. Anaphylaxis is fast in the beginning and cause serious health problems and sometimes death. The symptoms of anaphylaxis include itchy rashes, vomiting, breath shortness, tongue or throat swelling, low blood pressure, and lightheadedness. These all symptoms may last for a minute to an hour and may typically come on over and over again. The mechanism comprises of the release of mediators by either non-immunologic or immunologic mechanism from certain types of white blood cells activated. The primary anaphylaxis treatment includes epinephrine, steroids, and antihistamines through an oral or parenteral route of transmission. An additional dosage of epinephrine may require in some cases. Approximately 2% of the world population is expected to experience anaphylaxis at some point in life, globally. Worldwide the rates of anaphylaxis are increasing and mostly occurs in young population and females. In the United States, the percentage of the population admitted in the hospitals is very high and increasing and around 0.3% of the population die due to anaphylaxis.
Anaphylaxis Treatment: Market Dynamics
The increasing incidence of anaphylaxis globally is the main driving factor for the growth of the anaphylaxis treatment market. Additionally, innovative novel product launches by the major manufacturers contributing to the market growth of the anaphylaxis treatment market. For eg: in November 2018, Teva Pharmaceuticals, Inc. received FDA approval for epinephrine an auto-injector. It is the first generic equivalent to EpiPen, an emergency injectable anaphylaxis treatment. Increasing awareness regarding available anaphylaxis treatment options among patients and healthcare professionals are the boosting factors for the growth of the anaphylaxis treatment market. However, anaphylaxis treatment cost, lack of awareness in developing regions about the allergies and anaphylaxis treatment hampering the growth of anaphylaxis market. Moreover, side effects related to drugs used in the anaphylaxis treatment is expected to hinder the growth of the anaphylaxis treatment market.
Know More Details About the Report
Anaphylaxis Treatment market: Overview
Anaphylaxis is a very serious allergic reaction that needs to be treated as soon as possible. The introduction of auto-injectors for the anaphylaxis treatment act as the revolutionary medications for the anaphylaxis treatment. Additionally, manufacturer more focusing on delivering and expanding in the untapped market for expanding their revenue generation. Manufacturer delivering the low-cost generic version of drugs used for the anaphylaxis treatment such as Mylan N.V. has introduced EpiPen generic version at half price. Until 2016 it was sold at US$ 600 which was reduced to the price of US$ 300 in 2017. However, there are a large number of the patient which is underserved due to low medical facilities and unaware of the anaphylaxis reactions and treatments which may hamper the anaphylaxis treatment market growth.
Anaphylaxis Treatment market: Region-wise Outlook
The anaphylaxis treatment market in North America will show the high market growth in the global anaphylaxis treatment market due to rising anaphylaxis incidence, changing lifestyle and advanced healthcare infrastructure. Additionally, increasing awareness and availability of anaphylaxis treatment is boosting the market, followed by Europe. The anaphylaxis treatment market in the Asia-Pacific region will show moderate growth due to high negligence rate for anaphylaxis conditions and large underserved patients. Whereas, Latin America and the Middle East & Africa are expected to show constant anaphylaxis treatment market growth due to weak healthcare infrastructure and low awareness for anaphylaxis.
Avail customized purchase options for your needs
Anaphylaxis Treatment market: Key Players
Some of the key players present in global anaphylaxis treatment market are Impax Laboratories Inc., Lincoln Medical Ltd., Mylan N.V., Adamis Pharmaceutical Corporation, MannKind Corporation, Pfizer Inc., GlaxoSmithKline Plc., Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., ALK-Abelló, and others.
The report covers exhaustive analysis on:
- Anaphylaxis Treatment Market Segments
- Anaphylaxis Treatment Market Dynamics
- Anaphylaxis Treatment Market Size
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain
An Adaptive Approach to Modern-day Research Needs
The regional analysis includes:
- North America (U.S., Canada)
- Latin America (Mexico. Brazil)
- Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
- Eastern Europe (Poland, Russia)
- The Asia-Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
- The Middle East and Africa (GCC, S. Africa, N. Africa)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
An Adaptive Approach to Modern-day Research Needs
Anaphylaxis Treatment market: Segmentation
The global Anaphylaxis Treatment market is segmented by medication type, route of administration, allergy type, distribution channel and regions:
- Anaphylaxis Treatment Segmentation by Medication Type
- H2 blockers
- Anaphylaxis Treatment Segmentation by Route of Administration
- Anaphylaxis Treatment Segmentation by Allergy Type
- Food Allergy
- Insect Stings
- Latex Allergy
- Anaphylaxis Treatment Segmentation by Distribution Channel
- Hospital Pharmacies
- Retail Sales
- Drug Store
- Mail Order Pharmacies
Need an Exclusive Report for your Unique Requirement?
- Our Clients -
- Evaluate How Fact.MR's Report Can Help. -
Is the market research conducted by Fact.MR?
Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
What research methodology is followed by Fact.MR?
Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.
What are the sources of secondary research?
Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
Who are the respondents for primary research?
Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through an email.